Advertisement

Retrovirology

, 6:P52 | Cite as

P04-24. Frequencies of HIV Env-specific B cells and neutralizing antibodies during DNA-prime/protein-boost immunization with three different Env immunogens*

  • P Tawde
  • K Strouss
  • Z Kraft
  • M Gauduin
  • L Stamatatos
Open Access
Poster presentation
  • 596 Downloads

Keywords

Rhesus Macaque Immunization Strategy Robust Generation Multicolor Flow Cytometry Protein Boost 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Background

To address the challenging goal of eliciting broadly neutralizing antibodies (NAbs) to HIV, several immunization strategies have been employed so far with little success. We are interested in identifying immunization strategies that will aid in more robust generation of NAbs both in titer and sustainability. This study investigates the relationship between the frequencies of anti-HIV-1 Env B cells generated during DNA-prime protein-boost immunization with the titer of anti-Env antibodies, using three different Env immunogens.

Methods

Rhesus macaques were immunized with either soluble trimeric wild type gp140 (wt-gp140), or monomeric gp120 (m-gp120), or CD4-binding site mutant (D368R) gp140 (D368R-gp140). Throughout immunization, the frequency of HIV Env-specific B cells was evaluated by multicolor flow cytometry, anti-Env antibody titers by ELISA, and neutralization activity assayed using TZM-bl assay.

Results

The frequency of HIV Env specific plasmablast subset (CD3- CD20+ CD27high CD38 high) and titers of anti-Env antibodies increased as a result of protein boost in comparison with DNA prime in all immunized animals. The average frequency of Env specific B cells after protein immunization was 0.72% (0.47–0.99%) for the wt-gp140, 0.44% (0.35–0.52%) for the gp120, and 0.35% (0.13–0.56%) for the D368R gp140 immunized animals. However, no significant correlations can be drawn between the titer of Env specific antibodies and frequency of Env specific B cells in any group. The wt-gp140 was a more effective immunogen than m-gp120 in eliciting weak cross-NAbs. Interestingly, the wt-gp140 was also more effective in eliciting cross-NAbs than the D368Rgp140; potentially suggesting that the development of cross-NAbs by wt-gp140 depends on the structural integrity of the CD4-binding site.

Conclusion

Protein boosting is required for the development of high frequencies of anti-HIV Env antibodies, and ability of trimeric gp140 to elicit cross-NAbs will depend on the structural integrity of the CD4-binding site.

Acknowledgement

*Research was supported by National Institutes of Health grant number R01 AI047708-11.

Copyright information

© Tawde et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd.

Authors and Affiliations

  • P Tawde
    • 1
  • K Strouss
    • 1
  • Z Kraft
    • 1
  • M Gauduin
    • 2
  • L Stamatatos
    • 1
  1. 1.HIV Viral Vaccine ProgramSeattle Biomedical Research Institute (SBRI)SeattleUSA
  2. 2.Southwest Foundation for Biomedical ResearchSan AntonioUSA

Personalised recommendations